Literature DB >> 9225265

5-HT receptor classification and nomenclature: towards a harmonization with the human genome.

D Hoyer1, G Martin.   

Abstract

Molecular biology has dramatically advanced our knowledge and understanding of receptors for 5-hydroxytryptamine (5-HT). The existence of multiple 5-HT receptors defined using traditional pharmacological and biochemical approaches has now been amply confirmed, but gene products encoding putative "new" 5-HT receptors have also been discovered. In some cases, the absence of suitably selective agonists and antagonists has hampered determination of a physiological role for these gene products. This makes their classification as formally recognised receptors premature.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225265     DOI: 10.1016/s0028-3908(97)00036-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  50 in total

1.  Regulation of glial Na+/K+-ATPase by serotonin: identification of participating receptors.

Authors:  M T Peña-Rangel; R Mercado; J Hernández-Rodríguez
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

2.  Spatial memory alterations by activation of septal 5HT 1A receptors: no implication of cholinergic septohippocampal neurons.

Authors:  Julie Koenig; Lucas Lecourtier; Brigitte Cosquer; Patricia Marques Pereira; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2010-10-20       Impact factor: 4.530

3.  Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect.

Authors:  M T Klein; M Teitler
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity.

Authors:  Gang Chen; Sung Jin Cho; Xi-Ping Huang; Niels H Jensen; Andreas Svennebring; Maria F Sassano; Bryan L Roth; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2011-10-10       Impact factor: 4.345

Review 5.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.

Authors:  D W Bonhaus; L A Flippin; R J Greenhouse; S Jaime; C Rocha; M Dawson; K Van Natta; L K Chang; T Pulido-Rios; A Webber; E Leung; R M Eglen; G R Martin
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 7.  The serotonin 5-HT7 receptors: two decades of research.

Authors:  Evelien Gellynck; Karen Heyninck; Kjetil W Andressen; Guy Haegeman; Finn Olav Levy; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  Exp Brain Res       Date:  2013-09-17       Impact factor: 1.972

8.  A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.

Authors:  Johan Lundberg; Jacqueline Borg; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2007-09-15       Impact factor: 4.530

9.  Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.

Authors:  Jessica A Knight; Carol Smith; Nicole Toohey; Michael T Klein; Milt Teitler
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

10.  Contribution of transient receptor potential channels to the control of GABA release from dendrites.

Authors:  Thomas Munsch; Marc Freichel; Veit Flockerzi; Hans-Christian Pape
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.